Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Memed Diagnostics Ltd. has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are being handled by 4 distinct examiners across 3 distinct art units. This distribution shows a relatively broad prosecution effort for the company's diagnostic technologies. The use of 3 distinct art units suggests that the applications are categorized into several different technical groups, reflecting the diverse nature of the company's pharmaceutical and diagnostic innovations.
LY, KRISTINA ELISABETH is identified as the busiest examiner, though she only holds 1 pending office action. With 4 distinct examiners each managing a portion of the 4 pending office actions, the workload is evenly distributed among the individuals involved. This parity ensures that the portfolio's success is not tied to the decisions of a single examiner. However, the involvement of 4 distinct examiners means that practitioners must prepare for different sets of examination styles.
Practitioners managing this portfolio must navigate the requirements of 4 distinct examiners. The involvement of 3 distinct art units means that the prosecution strategy must be adapted to the specific standards of each group. Since LY, KRISTINA ELISABETH only holds 1 pending action, the individual influence of any one examiner is limited. This structure requires a coordinated effort to ensure consistency across the 4 pending office actions while respecting the nuances of the 3 distinct art units.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LY, KRISTINA ELISABETH | 1 | 37.5% | +100.0% |
| SALVOZA, M FRANCO G | 1 | 68.0% | +30.7% |
| ALLEN, MICHAEL D | 1 | 31.8% | +48.7% |
| QIAN, CELINE X | 1 | 47.5% | +17.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916577 | RNA MARKERS FOR DIAGNOSING INFECTIONS | SALVOZA, M FRANCO G | 34d |
| 18272838 | MARKERS FOR DIAGNOSING INFECTIONS | LY, KRISTINA ELISABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17796284 | METHODS OF DIAGNOSING AND CLASSIFYING VIRAL INFECTIONS | QIAN, CELINE X | 14d |
| 17955599 | RNA DETERMINANTS FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS | ALLEN, MICHAEL D | 28d |
| 17916577 | RNA MARKERS FOR DIAGNOSING INFECTIONS | SALVOZA, M FRANCO G | 34d |
| 18272838 | MARKERS FOR DIAGNOSING INFECTIONS | LY, KRISTINA ELISABETH | — |
| Art Unit | Apps |
|---|---|
| 1671 | 2 |
| 1672 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18272838 | MARKERS FOR DIAGNOSING INFECTIONS | LY, KRISTINA ELISABETH | 1671 | §103§112 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 17916577 | RNA MARKERS FOR DIAGNOSING INFECTIONS | SALVOZA, M FRANCO G | 1672 | §101§112 | Final Rejection | 34d | Pending | Oct 02, 2022 |
| 17955599 | RNA DETERMINANTS FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS | ALLEN, MICHAEL D | 1671 | §112 | Non-Final OA | 28d | Pending | Sep 29, 2022 |
| 17796284 | METHODS OF DIAGNOSING AND CLASSIFYING VIRAL INFECTIONS | QIAN, CELINE X | 1637 | §103 | Non-Final OA | 14d | Pending | Jul 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMemed Diagnostics Ltd. has 4 pending office actions as of November 2026, spread across 3 art units and 4 examiners.
Kristina Elisabeth Ly has the most, with 1 of Memed Diagnostics Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.